3D In Vitro Alveolar Lung Model for Respiratory Sensitization Assessment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current in vitro models lack the capability to accurately assess and predict the respiratory sensitization potential of inhalable chemicals and particles due to limitations in cell types and exposure methods, leading to inconclusive results and the reliance on animal studies for understanding lung sensitization mechanisms.

Innovation Solution

A three-dimensional in vitro alveolar lung model comprising alveolar type II epithelial cells, endothelial cells, dendritic-like cells, and macrophage-like cells, cultured with a porous membrane allowing cell migration, which mimics the alveolar surface and allows exposure at an air-liquid interface to assess the irritation and sensitizing effects of inhalable products.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional in vitro models use simple cell cultures without specific cell types and migration capability, then the model complexity is low and ease of operation is high, but the measurement precision and reliability for assessing respiratory sensitization potential are insufficient

Engineering Contradiction:
Improveassessment accuracy of respiratory sensitization potentialVSAvoidmodel structure complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The model segments the lung tissue into distinct cellular compartments (epithelial cells, endothelial cells, dendritic cells, macrophages) separated by a porous membrane, allowing each cell type to be cultured in its appropriate microenvironment while maintaining overall system functionality for sensitization assessment

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Different regions of the model provide specialized functions: the apical compartment supports epithelial cells and dendritic cell migration, the basolateral compartment houses endothelial cells and macrophages, and the porous membrane enables selective cell migration. This local differentiation enhances measurement precision without requiring complete system redesign

Inventive Principle:
Principle #3Local quality

2Measurement precision

If in vitro models use submerged culture conditions, then the ease of operation is high and device complexity is low, but the measurement precision for sensitization assessment deteriorates due to heterogeneous cell colonies and altered basal levels

Engineering Contradiction:
Improvesensitization assessment accuracyVSAvoidculture maintenance difficulty
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The model transitions from two-dimensional submerged culture to a three-dimensional air-liquid interface culture system, where cells are exposed to air on one side and culture medium on the other, better mimicking in vivo lung conditions and improving sensitization assessment accuracy

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Solution Approach 2:

The culture system dynamically maintains different environmental conditions in apical and basolateral compartments, with the porous membrane allowing controlled interaction between compartments while preserving distinct microenvironments necessary for accurate sensitization testing

Inventive Principle:
Principle #15Dynamics

3Reliability

If in vitro models use reduced pore size membranes, then the manufacturing precision and structural integrity are improved, but the reliability deteriorates due to inability to allow cell migration through the membrane

Engineering Contradiction:
Improvecell migration capability for sensitization assessmentVSAvoidmembrane pore size control
Core Design Contradiction:
ReliabilityVSManufacturing precision

Solution Approach 1:

The model employs a porous membrane with optimized pore architecture that balances structural integrity with cell migration capability, allowing dendritic cells and macrophages to traverse the barrier while maintaining sufficient mechanical strength for reliable sensitization assessment

Inventive Principle:
Principle #31Porous materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This model provides a more accurate and predictive tool for assessing the respiratory sensitization potential of inhalable products by mimicking the in vivo environment, allowing for the measurement of various biological endpoints and distinguishing between irritants and sensitizers, thereby reducing the need for animal testing.

Implementation Method 1

said porous membrane has pores comprised between 2 and 10 μm, allowing possible migration of the dendritic-like cells from the basolateral compartment to the apical compartment

Methodology Applied
Scientific EffectPermeation: Permeation

Implementation Method 2

The exposure at the ALI allows the realistic exposure to exogenous compounds without prior dilution in cell culture medium

Methodology Applied
Scientific EffectAbsorption: Absorption (physical)

Data Source

PatentUS11566233B2Three-dimensional in vitro lung model, process for preparing said model, and its use for determining and /or predicting the sensitizing effects of inhalable products
Publication Date: 2023.01.31 LUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGY (LIST)
  • US11566233B2 patent drawing
  • US11566233B2 patent drawing
  • US11566233B2 patent drawing

AI summary

The invention relates to a three-dimensional in vitro alveolar lung model comprising essentially the four cells types as follows: alveolar type II epithelial cells able to secrete (lung laying) surfactant, endothelial cells which forms the inner lining of capillaries providing a permeable barrier, dendritic-like cells, such as non-differentiated THP-1, linking innate and adaptive immunity and macrophage-like cells, able to participate to defense mechanisms by ingesting foreign materials by phagocytosis.The invention also relates to a process for preparing said model, and its use for assessing the irritation potential or toxicity of inhalable products such as particles or molecules on the alveolar barrier of lungs, and also for determining and/or predicting the sensitizing effects of inhalable products such as particles or molecules on the alveolar barrier of lungs.